APA (7th ed.) Citation

Morra, A., Schreurs, M. A. C., Andrulis, I. L., Anton-Culver, H., Augustinsson, A., Beckmann, M. W., . . . Lund University, F. o. M. (2023). Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival. Cancer Medicine, 12(15), 16142. https://doi.org/10.1002/cam4.6272

Chicago Style (17th ed.) Citation

Morra, Anna, et al. "Association of the CHEK2 C.1100delC Variant, Radiotherapy, and Systemic Treatment with Contralateral Breast Cancer Risk and Breast Cancer-specific Survival." Cancer Medicine 12, no. 15 (2023): 16142. https://doi.org/10.1002/cam4.6272.

MLA (9th ed.) Citation

Morra, Anna, et al. "Association of the CHEK2 C.1100delC Variant, Radiotherapy, and Systemic Treatment with Contralateral Breast Cancer Risk and Breast Cancer-specific Survival." Cancer Medicine, vol. 12, no. 15, 2023, p. 16142, https://doi.org/10.1002/cam4.6272.